Company / EPS (Diluted)
Beam Therapeutics Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.81
FY2025
5-year range
-$5.77 / -$0.81
FY2021-FY2025
Trend
+82.3%
vs FY2024
Sector context
#82 of 204
Health Care
What the data says
At $-0.81, Beam Therapeutics Inc.'s eps (diluted) ranks #82 of 204 in the Health Care sector. Improved from $-1.72 to $-0.81 over the past 2 years.
Based on SEC 10-K filings.
-0.81 in FY2025.
Improved from $-1.72 to $-0.81 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#82 of 204 in Health CareTop 40% of 204This company -$0.81 Sector average -$0.89
▼
+8.6% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 82.3% year-over-year.
- Ranks #82 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.81 | +82.3% |
| FY2024 | -$4.58 | -166.3% |
| FY2023 | -$1.72 | +58.4% |
| FY2022 | -$4.13 | +28.4% |
| FY2021 | -$5.77 | +58.9% |
| FY2020 | -$14.05 | +0.0% |
| FY2019 | -$14.05 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026